Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of ivabradine on cardiovascular events in patients with coronary artery disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut de Recherches Internationales Servier; Servier

Criteria

Inclusion Criteria:

• Evidence of coronary artery disease

• Sinus rhythm and resting heart rate equal or higher than 70 bpm

Exclusion Criteria:

• Unstable cardiovascular condition

• Known hypersensitivity to ivabradine or current treatment with marketed ivabradine